imaavy 1,200 MG in 6.5 ML Injection
- RxCUI
- 2712709
- RxNorm name
- imaavy 1,200 MG in 6.5 ML Injection
- Display name
- imaavy 1,200 MG in 6.5 ML Injection
- Full name
- imaavy 1,200 MG in 6.5 ML Injection
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:07
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 761430 | Imaavy | nipocalimab-aahu | 351(a) | Rx | 2026-07-01 |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| IMAAVY | NIPOCALIMAB-AAHU | Janssen Biotech, Inc. | 8886274c-f2b2-48af-85c1-2f90bfe304b8 | 2025-05-07 | Warnings, Adverse reactions | 2712709 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 8886274c-f2b2-48af-85c1-2f90bfe304b8 | imaavy 1,200 MG in 6.5 ML Injection | PSN | 4 | These highlights do not include all the information needed to use IMAAVY safely and effectively. See full prescribing information for IMAAVY. IMAAVY™ (nipocalimab-aahu) injection, for intravenous use Initial U.S. Approval: 2025 | 20250507 |
| 8886274c-f2b2-48af-85c1-2f90bfe304b8 | 6.5 ML nipocalimab-aahu 185 MG/ML Injection [Imaavy] | SBD | 4 | These highlights do not include all the information needed to use IMAAVY safely and effectively. See full prescribing information for IMAAVY. IMAAVY™ (nipocalimab-aahu) injection, for intravenous use Initial U.S. Approval: 2025 | 20250507 |
| 8886274c-f2b2-48af-85c1-2f90bfe304b8 | Imaavy 1200 MG per 6.5 ML Injection | SY | 4 | These highlights do not include all the information needed to use IMAAVY safely and effectively. See full prescribing information for IMAAVY. IMAAVY™ (nipocalimab-aahu) injection, for intravenous use Initial U.S. Approval: 2025 | 20250507 |